totipotent capital
NOT JUST ANOTHER
INVESTOR
Totipotent Capital is cultivating a portfolio of early-stage ventures that are disruptively innovating healthcare access, procurement and disease management. We are industry experts in healthcare, digital health and health tech.
50%
Healthcare services
25%
Providers
25%
Founders/Operators
LATEST
INVESTMENTS
INVESTMENT CRITERIA
STRONG
TEAM
We look for management teams that are experienced or demonstrate a mature understanding of their needs
INDUSTRY EXPERTISE
The business reflects an understanding of the industry
MARKET AWARENESS
The founder's go-to-market strategy incorporates current policy trends
THE INVESTORS
SHANA LAWLOR
ADAM MARKS
DALE VAN DEMARK
Shana Lawlor is the Managing Partner of 2raze and Totipotent Capital. She is a Limited Partner in Rock Health Capital and an investor in Health Tech Capital. She is the Board President for Health Tech-X, a digital health entrepreneur and consultant. She was named “Trending 40 Power Woman in DC Tech.” She previously worked at Booz Allen, Arthur Anderson and PwC.
Dale C. Van Demark is a Co-Founder and Partner of Totipotent Capital. He is in the Health Practice at McDermott Will & Emery. He works at the forefront of strategic transactions and digital health matters in the health, life sciences and technology industries. He is a Limited Partner in Rock Health Capital and an investor in Health Tech Capital. He is also on the Board of Health Tech-X and serves on the advisory council of the Children’s Health Fund.
DR. GOPAL BAJAJ MD
Adam R. Marks is a Partner in Totipotent Capital. He is in the Health Practice at McDermott Will & Emery. He represents hospitals, health systems, and other health industry providers and investors in transactional matters, including mergers, acquisitions, affiliations and joint ventures. He is a Limited Partner in Rock Health Capital and an investor in Health Tech Capital.
Dr. Bajaj is a Partner in Totipotent Capital. He is the President of Radiation Oncology Associates, PC and the emeritus Chairman and Medical Director of the Department for Advanced Radiation Oncology and Proton Therapy for the Inova Schar Cancer Institute, having served in this role from 2014-2020. He is a Limited Partner in Rock Health Capital and an investor in Health Tech Capital.
ENTREPRENEURS
Totipotent Capital is stage agnostic. Funding ranges between $40K and $150K. We hold pitch meetings bi-monthly. The window to submit your information for review closes each Tuesday by COB. If you submit your information on a Wednesday, it will be reviewed the following week. Please complete your company summary using the "Submit Company Summary" button below
INVESTORS
If you are interested in investing alongside Totipotent Capital, please contact us through this form.